Symbol
| CLDN11
| contributors: mct - updated : 02-02-2022
|
HGNC name
| claudin 11
|
HGNC id
| 8514
|
corresponding disease(s)
|
HLD22
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
by hypermethilation in nasopharyngeal carcinoma (NPC)![](pubmed.jpg) | tumoral
|  
|  
| --low
|  
|
by hypermethylation is associated with metastasis of colorectal cancer (CRC) and prognosis of poor survival of CRC ![](pubmed.jpg) | tumoral
|  
|  
| --low
|  
|
in malignant melanoma (MM) of the skin by hypermethylation ![](pubmed.jpg) | constitutional
|  
|  
| --over
|  
|
in spermatogenic defect in human testes ![](pubmed.jpg) | constitutional
|  
|  
| --other
|  
|
disorganization of claudin-11 expression in Sertoli cells might be one of the factors involved in the impairment of spermatogenesis ![](pubmed.jpg) | |
Susceptibility
|
to autoimmune disease (potential autoantigen in the development of autoimmune demyelinating disease) |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| | | |
| Cldn11 deficiency in mice results in loss of the Sertoli cell epithelial phenotype in the testisCldn11 null mice lack CNS myelin and Sertoli cell tight junction strands ![](pubmed.jpg) |